NCS Multistage(NCSM) Newsfile·2025-03-12 13:27Core Insights - NCS Multistage Holdings, Inc. (NCSM) reported a 28% year-over-year increase in total revenues for Q4 2024, reaching $45.0 million [1][6] - The growth was primarily driven by a significant rise in international revenues, particularly from the Middle East tracer diagnostics projects, and a 19.5% increase in Canada [1] - U.S. results were mixed, with product sales increasing by 29.1% while services revenues decreased by 9.5% [1] - The company expects modest revenue growth through FY25 despite potential tariff increases [1] - Consolidated gross margins improved from 36.6% in Q4 2023 to 43.1% in Q4 2024 [1] Financial Performance - Total revenues for Q4 2024 were $45.0 million, marking a 28% year-over-year improvement [6] - The liquidity position of the company increased to $46.0 million from $37.0 million in Q3 2024 [6] - Adjusted EBITDA for the quarter was $8.2 million, reflecting a $5.7 million year-over-year improvement [6]